Sangro B, Melero I, Yau T, et al. Nivolumab in Sorafenib-Naive and -Experienced Patients With Advanced Hepatocellular Carcinoma (HCC): Survival, Hepatic Safety, and Biomarker Assessments in CheckMate 040. AAASLD 2017, Presidential Poster of Distinction 141.
PARP- plus checkpointremming verbetert PFS bij gevorderd pancreascarcinoom
jul 2022 | Immuuntherapie, Maag-darm-leveroncologie